Mar 16,2021 Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021 read more >>
Feb 05,2021 CULLGEN CLOSES $50 MILLION SERIES B INVESTMENT TO ADVANCE TARGETED PROTEIN DEGRADERS AND NOVEL E3 LIGANDS PLATFORM read more >>
Jan 06,2021 C4 Therapeutics Announces Key 2021 Milestones to Support Progress Toward Goal of Four Clinical-Stage Programs by Year-End 2022 read more >>
Nov 18,2020 Twist Bioscience Ranked 60th Fastest Growing Company in North America on Deloitte’s 2020 Fast 500™ read more >>
Nov 12,2020 Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA read more >>
Nov 11,2020 Immune-Onc Therapeutics Announces Orphan Drug Designation of IO-202 (Anti-LILRB4) for Treatment of AML and Poster Presentation at ASH 2020 read more >>